Income StatementBalance SheetCash FlowSegments
PLY

Polaryx Therapeutics, Inc. Income Statement

Revenue, expenses, and profitability over time
Operating Income-$2.0MNet Income-$2.5MEps Diluted$-0.05
Market Cap$161.4M

Earnings Per Share

MetricQ1 '25Q1 '26
Basic earnings per share$-0.11$-0.05
Diluted earnings per share$-0.11$-0.05
Weighted-average shares, basic44338960.0047219329.00
Weighted-average shares, diluted44338960.0047219329.00

Operating Expenses

MetricQ1 '25Q1 '26
General and administrative$336.0K$1.3M
Other Expense Direct Listing Offering Costs—$586.0K
Other operating expenses$5.1M$2.0M
Research and development$4.7M$679.0K
Total operating expenses$5.1M$2.0M

Net Income

MetricQ1 '25Q1 '26
Net income-$5.1M-$2.5M

Operating Income

MetricQ1 '25Q1 '26
Operating income-$5.1M-$2.0M